Teva Manufacturing locations form a global network that supports reliable access to critical therapies. This overview highlights how facilities are organized, quality standards are maintained, and operations align with patient needs.
Each site follows strict regulatory expectations and connects through integrated systems that coordinate production, logistics, and continuous improvement.
| Facility | Region | Therapeutic Focus | Certifications |
|---|---|---|---|
| Kfar Saba | Israel | Neurology & Hospital Care | ISO 13485, GMP |
| Freeburg | United States | Branded Generics & Respiratory | FDA cGMP, ISO 9001 |
| Gedera | Israel | Injectables & Sterile Products | ISO 13485, PIC/S |
| Holziken | Switzerland | API Synthesis & Specialty Ingredients | ISO 9001, Swissmedic |
| Patancheru | India | Advanced Therapies & Export Manufacturing | WHO GMP, ISO 9001 |
Global Network Strategy and Patient Access
Diverse Geographies for Supply Chain Resilience
Teva Manufacturing locations span multiple continents to reduce risk and respond to regional demand. By distributing production across Israel, the United States, Switzerland, and India, the network maintains continuity during local disruptions. This geographic diversity supports consistent availability of essential medicines for communities worldwide.
Centralized Quality and Decentralized Operations
Each Teva Manufacturing site operates under a unified quality management framework. Standardized procedures, shared digital tools, and regular cross-site audits ensure that expectations remain consistent. Patients and healthcare providers can trust that every authorized facility meets the same high benchmarks for safety, identity, strength, and purity.
Innovation and Continuous Improvement in Manufacturing
Investment in Modern Facilities and Technology
Ongoing upgrades across Teva Manufacturing locations incorporate automation, real-time data monitoring, and advanced analytics. These technologies help detect trends early, reduce variability, and optimize processes. As a result, the network can scale production efficiently while preserving flexibility for new treatments.
Sustainability and Regulatory Alignment
Environmental considerations and energy efficiency are integrated into site decisions, reflecting long term operational responsibility. Regular engagement with regulators ensures that facilities stay aligned with the latest requirements. This proactive approach supports uninterrupted patient access and maintains stakeholder confidence.
Strategic Growth and Pipeline Support
Expanding Capacity for Future Therapies
Active projects at several Teva Manufacturing locations focus on increasing capacity for complex dosage forms, including biologics and targeted treatments. By aligning infrastructure investments with pipeline needs, the network prepares to support next generation therapies. Teams collaborate across sites to share best practices and accelerate technology transfer.
Partnerships and Collaborative Development
Collaborations with research institutions and contract development partners enhance capabilities at key facilities. These relationships enable access to specialized expertise in formulation, process development, and analytical testing. Through coordinated effort, Teva Manufacturing locations can bring innovative solutions to market more efficiently.
Key Operations and Patient Commitment
- Maintain global coverage with strategically located Teva Manufacturing locations
- Apply consistent quality standards across every authorized site
- Invest in technology, automation, and sustainability upgrades
- Align capacity planning with product pipeline and patient needs
- Enable traceability and transparency through serialization and reporting
FAQ
Reader questions
How do Teva Manufacturing locations ensure consistent product quality across countries?
A unified global quality system, common standards, and regular audits help maintain consistent quality at every authorized Teva Manufacturing location, supported by shared digital tools and cross-site reviews.
What happens during a disruption at one facility in the network?
Robust contingency plans, including inventory buffers and alternate sourcing options, help maintain continuity when a single Teva Manufacturing location faces temporary disruption, protecting patient access.
Can patients verify that their medication comes from a compliant Teva Manufacturing location?
Serialized packaging, batch traceability, and regulatory documentation allow healthcare professionals and patients to confirm that a product was manufactured in accordance with applicable standards at a verified Teva Manufacturing location.
How does the network decide where to build or expand a Teva Manufacturing location?
Decisions consider patient demand, therapeutic priorities, regulatory landscape, and operational efficiency, with a focus on strengthening access to essential medicines in key markets through strategically placed Teva Manufacturing locations.